Genome-wide analysis of somatic noncoding mutation patterns in cancer

Area of Science:

• Genomics
• Cancer Biology
• Molecular Oncology

Background:

• Somatic mutations are key drivers of cancer development.
• Understanding noncoding mutations is crucial for comprehensive cancer genomics.
• Previous studies have focused primarily on protein-coding mutations.

Purpose of the Study:

• To establish a genome-wide compendium of somatic mutation events across diverse cancer types.
• To identify potential drivers within noncoding regulatory regions.
• To explore the functional impact of noncoding mutations on gene expression.

Main Methods:

• Whole-genome sequencing of 3949 cancer samples across 19 tumor types.
• Analysis of both protein-coding and noncoding mutation events.
• CRISPR-interference screening and luciferase reporter assays for functional validation.

Main Results:

• A comprehensive catalog of somatic mutations in 3949 whole cancer genomes was created.
• Noncoding mutations in regulatory regions were associated with cancer-relevant genes (e.g., TERT, XBP1).
• Specific noncoding mutations, particularly in XBP1, were validated to affect gene expression.

Conclusions:

• Noncoding mutations represent a significant source of potential cancer drivers.
• This genome-wide mutation compendium provides a blueprint for future biological discovery.
• The findings have implications for advancing cancer therapies and diagnostics.